Guest Contributors

Levine, Daniel Managing Director, Burrill & Company	Danny Levner Daniel Levner Co-Founder and Chairman of the Scientific Advisory Board, Sight Dx	Jimmy Lin Founder, Rare Genomics Institute
Lin, Dawei, PhD Director of the Bioinformatics Core at UC Davis Genome Center	Shirley Liu Shirley Liu, Professor of Biostatisitcs at Harvard, Co-Director of the Center for Fuctional Cancer Epigenetics at the Dana Farber Cancer Institute	Matt Loose Matt Loose, Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham
Lu, Yi, PhD Professor, University of Illinois	Lustig, Kevin, PhD CEO, Assay Depot	Elaine Lyon Clinical Services Lab Director at HudsonAlpha Institute for Biotechnology
Gholson Lyon @GholsonLyon	Sandy Macrae Sandy Macrae, CEO of Sangamo	Maderis, Gail President and CEO, BayBio
Malow, Brian Science Comedian	Elizabeth Mansfield Deputy Office Director of Personalized Medicine, OIR, FDA	Marco Marra Professor and Head, Department of Medical Genetics, University of British Columbia
Annie Martin Annie Martin, SVP, Global Head of Precision Medicine, Novartis	Trey Martin Chief Operating Officer, IDT	Martin, Hugh former CEO, Pacific Biosciences
Rodrigo Martinez Rodrigo Martinez, Chief Marketing and Design Officer at Veritas	Marton, Laurence, MD Program Chair, PMWC	Christopher Mason Assistant Professor, Weill Cornell Medical College
Nola Masterson Founder, Science Futures	Ellen Matloff President and CEO, My Gene Counsel	Charles Matthews VP, Boston Healthcare
Shannon McCall Associate Professor, Leader of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University